Skip to main content

DIADEMA PARTNERS LP

Position in ATYR — aTYR PHARMA INC

CIK 2026172 MORRISTOWN, NJ

Position in ATYR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
6 quarters on record

Derivatives in ATYR

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$7,462
PutShares
12,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ATYR

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,462 12,500
2026-03-31 $9,750 12,500
2026-03-31 $9,516 12,200
2025-12-31 $9,239 11,800
2025-12-31 $12,136 15,500
2025-09-30 $54,940 76,200
2025-09-30 $92,792 128,700
2025-06-30 $652,509 128,700
2025-06-30 $386,334 76,200
2025-03-31 $35,636 11,800
2025-03-31 $165,194 54,700